Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

This publication has 31 references indexed in Scilit:

• Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.
  British Journal of Clinical Pharmacology, 1995
• Effect of Entacapone, a COMP Inhibitor, on the Pharmacokinetics and Metabolism of Levodopa After Administration of Controlled-Release Levodopa-Carbidopa in Volunteers
  Clinical Neuropharmacology, 1995
• Control of respiration and ATP synthesis in mammalian mitochondria and cells
  Biochemical Journal, 1992
• Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement
  Journal of Neurochemistry, 1992
• Application and validation of an ion-exchange high-performance liquid chromatographic method for measuring adenine nucleotides, creatine and creatine phosphate in mouse brain
  Journal of Chromatography B: Biomedical Sciences and Applications, 1990
• MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
  The Lancet, 1989
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes
  Biochemical and Biophysical Research Communications, 1986
• THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEM
  Annual Review of Biochemistry, 1985
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Lipid solubility as a factor influencing the activity of uncoupling phenols
  Biochimica et Biophysica Acta, 1962